Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.57 - $0.88 $3,781 - $5,838
6,635 Added 7291.21%
6,726 $5,000
Q1 2023

May 09, 2023

SELL
$0.61 - $1.03 $2,562 - $4,326
-4,200 Reduced 97.88%
91 $0
Q4 2022

Feb 10, 2023

SELL
$0.62 - $1.21 $20,465 - $39,940
-33,009 Reduced 88.5%
4,291 $3,000
Q3 2022

Nov 10, 2022

BUY
$1.05 - $2.1 $33,921 - $67,842
32,306 Added 646.9%
37,300 $39,000
Q2 2022

Aug 15, 2022

SELL
$1.42 - $3.15 $28,111 - $62,360
-19,797 Reduced 79.86%
4,994 $8,000
Q1 2022

May 12, 2022

BUY
$2.65 - $5.08 $60,274 - $115,544
22,745 Added 1111.68%
24,791 $72,000
Q4 2021

Feb 14, 2022

BUY
$4.73 - $7.9 $4,323 - $7,220
914 Added 80.74%
2,046 $10,000
Q3 2021

Nov 15, 2021

SELL
$5.16 - $7.98 $33,498 - $51,806
-6,492 Reduced 85.15%
1,132 $9,000
Q2 2021

Aug 16, 2021

SELL
$6.45 - $9.09 $6,830 - $9,626
-1,059 Reduced 12.2%
7,624 $57,000
Q1 2021

May 17, 2021

SELL
$7.25 - $13.82 $14,529 - $27,695
-2,004 Reduced 18.75%
8,683 $68,000
Q4 2020

Feb 16, 2021

BUY
$6.87 - $10.48 $72,045 - $109,903
10,487 Added 5243.5%
10,687 $99,000
Q3 2020

Nov 16, 2020

BUY
$5.06 - $7.23 $1,011 - $1,446
200 New
200 $1,000
Q2 2020

Aug 13, 2020

SELL
$1.57 - $6.56 $16,817 - $70,270
-10,712 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.44 - $3.95 $7,014 - $19,240
4,871 Added 83.39%
10,712 $20,000
Q4 2019

Feb 07, 2020

SELL
$1.17 - $2.33 $22,997 - $45,798
-19,656 Reduced 77.09%
5,841 $11,000
Q3 2019

Nov 05, 2019

BUY
$1.4 - $2.84 $27,274 - $55,328
19,482 Added 323.89%
25,497 $36,000
Q2 2019

Aug 13, 2019

SELL
$2.75 - $4.89 $22,057 - $39,222
-8,021 Reduced 57.15%
6,015 $17,000
Q1 2019

May 14, 2019

BUY
$4.11 - $5.88 $46,771 - $66,914
11,380 Added 428.46%
14,036 $67,000
Q4 2018

Feb 14, 2019

BUY
$3.65 - $10.69 $3,084 - $9,033
845 Added 46.66%
2,656 $11,000
Q3 2018

Nov 13, 2018

BUY
$8.92 - $17.83 $16,154 - $32,290
1,811 New
1,811 $20,000

Others Institutions Holding SURF

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.